Strom Tb

788 total citations
57 papers, 633 citations indexed

About

Strom Tb is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Strom Tb has authored 57 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Transplantation, 22 papers in Immunology and 21 papers in Surgery. Recurrent topics in Strom Tb's work include Renal Transplantation Outcomes and Treatments (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Transplantation: Methods and Outcomes (7 papers). Strom Tb is often cited by papers focused on Renal Transplantation Outcomes and Treatments (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Transplantation: Methods and Outcomes (7 papers). Strom Tb collaborates with scholars based in United States and Germany. Strom Tb's co-authors include Carpenter Cb, Tilney Nl, Michael Shapiro, Milford El, Manikkam Suthanthiran, Peter Nickerson, S J Burakoff, HJ Weinstein, R.J. Arceci and Kyri Dunussi‐Joannopoulos and has published in prestigious journals such as Blood, American Journal of Kidney Diseases and PubMed.

In The Last Decade

Strom Tb

55 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Strom Tb United States 14 284 198 137 120 102 57 633
Carpenter Cb United States 15 221 0.8× 261 1.3× 194 1.4× 109 0.9× 76 0.7× 82 665
Mayra Lopez‐Cepero United States 12 216 0.8× 324 1.6× 306 2.2× 144 1.2× 76 0.7× 22 711
Mariano F. LaVia United States 12 111 0.4× 105 0.5× 70 0.5× 37 0.3× 128 1.3× 22 472
Thomas Pham United States 15 174 0.6× 103 0.5× 284 2.1× 114 0.9× 141 1.4× 31 711
Rafik Ghobrial United States 9 165 0.6× 110 0.6× 125 0.9× 24 0.2× 82 0.8× 16 394
William P. Stefura Canada 11 108 0.4× 197 1.0× 146 1.1× 84 0.7× 38 0.4× 17 452
G Ramadori Germany 13 101 0.4× 81 0.4× 172 1.3× 247 2.1× 75 0.7× 44 666
Chuanmin Wang Australia 17 416 1.5× 267 1.3× 393 2.9× 99 0.8× 111 1.1× 45 909
Éva Kemény Hungary 15 86 0.3× 227 1.1× 106 0.8× 37 0.3× 141 1.4× 38 660
Martin Huisman Netherlands 12 260 0.9× 51 0.3× 112 0.8× 205 1.7× 86 0.8× 22 776

Countries citing papers authored by Strom Tb

Since Specialization
Citations

This map shows the geographic impact of Strom Tb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Strom Tb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Strom Tb more than expected).

Fields of papers citing papers by Strom Tb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Strom Tb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Strom Tb. The network helps show where Strom Tb may publish in the future.

Co-authorship network of co-authors of Strom Tb

This figure shows the co-authorship network connecting the top 25 collaborators of Strom Tb. A scholar is included among the top collaborators of Strom Tb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Strom Tb. Strom Tb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snydman, David R., Tilney Nl, Milford El, et al.. (1991). Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.. PubMed. 23(1 Pt 2). 1357–60. 25 indexed citations
2.
El, Milford, Tilney Nl, Strom Tb, et al.. (1989). In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.. PubMed. 102. 231–9. 3 indexed citations
3.
Shapiro, Michael, et al.. (1989). Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.. PubMed. 21(1 Pt 1). 1028–30. 1 indexed citations
4.
Shapiro, Michael, et al.. (1989). The role of a primate model of renal transplantation in the development of new monoclonal antibodies.. American Journal of Kidney Diseases. 14(5 Suppl 2). 58–60. 2 indexed citations
5.
Shapiro, Michael, Carpenter Cb, Milford El, et al.. (1989). Early experience with anti-Tac in clinical renal transplantation.. PubMed. 21(1 Pt 2). 1766–8. 36 indexed citations
6.
Murphy, et al.. (1989). Immunotherapy using interleukin-2 diphtheria toxin chimer prolongs murine allografts.. PubMed. 21(1 Pt 3). 2718–9. 3 indexed citations
7.
Volk, Hans‐Dieter, Αthanasia Mouzaki, George Tellides, et al.. (1988). Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.. PubMed. 20(2 Suppl 2). 207–16. 14 indexed citations
8.
Tb, Strom, et al.. (1987). Requirements for primary T cell activation.. PubMed. 19(1 Pt 1). 331–2. 1 indexed citations
9.
Nl, Tilney, et al.. (1986). Long-term results of cyclosporine treatment in renal transplantation.. PubMed. 18(2 Suppl 1). 179–85. 15 indexed citations
10.
Tb, Strom, et al.. (1986). Treatment with anti-interleukin-2 receptor monoclonal antibody.. PubMed. 224. 227–38. 3 indexed citations
11.
Abbud‐Filho, Mário, D Araneda, J. Stadler, et al.. (1985). Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.. PubMed. 40(4). 441–4. 39 indexed citations
12.
Tb, Strom, Tilney Nl, & Carpenter Cb. (1981). Kidney transplantation in the treatment of terminal uremia.. PubMed. 13(4-5). 224–43. 1 indexed citations
13.
Tb, Strom, et al.. (1981). B-cell alloantigen matching by the lymphocyte insulin receptor assay.. PubMed. 13(1 Pt 2). 1042–3. 2 indexed citations
14.
El, Milford, Carpenter Cb, Strom Tb, & Tilney Nl. (1981). Suppression of renal allograft rejection by low density thymocytes.. PubMed. 13(1 Pt 1). 626–8. 2 indexed citations
15.
Tb, Strom & Carpenter Cb. (1980). Cyclic nucleotides in immunosuppression--neuroendocrine pharmacologic manipulation and in vivo immunoregulation of immunity acting via second messenger systems.. PubMed. 12(2). 304–10. 20 indexed citations
16.
Tb, Strom, et al.. (1978). Intragraft immune events causing vascularized organ graft rejection.. PubMed. 10(2). 389–94. 4 indexed citations
17.
Nl, Tilney, et al.. (1977). Identification, cytotoxicity, and suppressor activity of infiltrating cells from enhanced organ allografts.. PubMed. 9(1). 713–5. 7 indexed citations
18.
Tb, Strom, et al.. (1976). T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 272–80. 27 indexed citations
19.
Nl, Tilney, Strom Tb, J Bancewicz, & Carpenter Cb. (1975). Studies on living cells harvested from acutely rejecting and enhanced rat cardiac allografts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26. 349–50. 1 indexed citations
20.
Tb, Strom, et al.. (1973). Regulatory role of the cyclic nucleotides in alloimmune lymphocyte mediated cytotoxicity. Effect of imidazole.. PubMed. 5(1). 425–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026